$TMO News

HSBC Downgrades Thermo Fisher Scientific (TMO)

HSBC Downgrades Thermo Fisher Scientific to Hold, Lowers Price Target to $540

Is Thermo Fisher Scientific (TMO) Pricing Look Interesting After Recent Share Price Swings

Wolfe Research Assumes Thermo Fisher Scientific at Outperform, Announces Price Target of $535

Thermo Fisher Scientific Expands Orbitrap Innovation Across Research, Biopharma and Applied Testing at ASMS 2026

Thermo Fisher Unveils AI Orbitraps And Swedish Labs As Valuation Lags

Is Thermo Fisher Scientific Stock Underperforming the S&P 500?

Thermo Fisher (TMO) Surges 6.8%: Is This an Indication of Further Gains?

Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies

Is Thermo Fisher Scientific Inc. (TMO) a Buy as RBC Restarts Coverage With Sector Perform Rating?

Thermo Fisher (TMO) Sets a Bold 7% Annual Growth Target at Its 2026 Investor Day

If You Invested $1000 In Thermo Fisher Scientific Stock 20 Years Ago, You Would Have This Much Today

What Thermo Fisher Scientific (TMO)'s New Gothenburg Lab Expansion Means For Shareholders

[Latest] Global Genome Editing Market Size/Share Worth USD 55.7 Billion by 2035 at a 17.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Thermo Fisher Scientific Announces Quarterly Dividend

Thermo Fisher Scientific Highlights Industry Leadership, Growth Outlook and Long-Term Value Creation at 2026 Investor Day

Thermo Fisher Scientific Targets 7% Organic Revenue CAGR And Low-Teens Adj EPS Growth Long Term

Global Cell Culture Media Market Outlook 2026-2036: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG

Thermo Fisher Scientific’s PPD Clinical Research Business Expands Bioanalytical Capabilities with New Laboratory in Gothenburg, Sweden

Life Science Instrumentation Market Forecast Report 2025-2031: Expanding Activities in Genomics, Proteomics, and Drug Discovery with Thermo Fisher Scientific, Danaher, Agilent, and Shimadzu Leading